Changes in Neurodevelopmental Outcomes From Age 2 to 10 Years for Children Born Extremely Preterm
Overview
Authors
Affiliations
Objectives: Evidence-based care of extremely preterm infants (<28 weeks' gestation) depends heavily on research in which a primary outcome is infant neurodevelopmental impairment (NDI), yet it is unclear how well NDI in infancy predicts long-term NDI. In this study, we aim to assess the relationship between 2- and 10-year neurodevelopment using a well-known 2-year definition and a 10-year definition developed by an expert panel.
Methods: Using data from the Extremely Low Gestational Age Newborn Study cohort, we classified 2-year NDI using definitions developed by the National Institute of Child Health and Human Development Neonatal Research Network. We classified 10-year NDI using definitions developed by an expert panel, which added epilepsy and ASD at 10 years.
Results: Of 1506 infants, 80% survived. Data sufficient to classify severity of NDI at both 2 and 10 years were available for 67% of survivors ( = 802). Among children classified as having moderate to severe NDI at 2 years, 63% had none to mild NDI at 10 years; among children classified as having profound NDI at 2 years, 36% had none to mild NDI at 10 years. Cohen's κ statistic indicated minimal to fair agreement between NDI at 2 and 10 years (0.34, < .001).
Conclusions: NDI in infancy, as defined in this study, only weakly predicts NDI in middle childhood. For the parents at risk for delivery of an extremely preterm infant, a hopeful message can be taken from our findings that one-third of surviving children classified as having profound NDI and nearly two-thirds of those classified as having moderate to severe NDI at 2 years had none to mild NDI at 10 years.
Watanabe K, Ogata R, Kajiwara K, Inoue H, Sakemi Y, Ichiyama M Sci Rep. 2025; 15(1):4504.
PMID: 39915669 PMC: 11802728. DOI: 10.1038/s41598-025-88721-x.
Arimitsu T, Hatayama K, Gaughwin K, Kusuda S Eur J Pediatr. 2025; 184(2):140.
PMID: 39814940 DOI: 10.1007/s00431-025-05976-2.
Dorner R, Li L, DeMauro S, Schmidt B, Zangeneh S, Vaucher Y J Pediatr. 2024; 278:114428.
PMID: 39643110 PMC: 11867846. DOI: 10.1016/j.jpeds.2024.114428.
Katz T, van Kaam A, Zuithoff N, Mugie S, Beuger S, Blok G Arch Dis Child Fetal Neonatal Ed. 2024; 110(1):51-56.
PMID: 38897634 PMC: 11671953. DOI: 10.1136/archdischild-2024-326931.
Retinopathy of prematurity and neurodevelopmental outcome and quality of life at 10 years of age.
Sriram S, Jensen E, Msall M, Yi J, Zhabotynsky V, Joseph R Res Sq. 2024; .
PMID: 38766141 PMC: 11100895. DOI: 10.21203/rs.3.rs-4324566/v1.